How Changes To The Declaration Of Helsinki Impact Clinical Trials

by Jessica Cordes  - November 18, 2024

Guest Column | November 18, 2024

How Changes To The Declaration Of Helsinki Impact Clinical Trials

By Jessica Cordes, senior consultant, Clinical Excellence GmbH

One hand is holding text document, another hand are editing content with red pen. Concept of text editing, error correcting, proofreading and spelling check. Document preparation before publication

The World Medical Association (WMA) formulated the Declaration of Helsinki to outline ethical principles for conducting medical research involving human participants, including studies utilizing identifiable human material or data. This Declaration is designed to be read comprehensively, with each paragraph considered in the context of all other relevant sections. Although primarily adopted by physicians, the WMA maintains that these principles should be adhered to by all individuals, teams, and organizations engaged in medical research, as they are essential for ensuring respect and protection for all research participants, encompassing both patients and healthy volunteers.

The latest version, issued in 2024, builds upon the previous version from 2013 with notable updates and revisions.

Please read the full Clinical Leader Article.

bonus

Get a Checklist with Critical Processes and Records

Free

About 

Jessica Cordes

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

You may be interested in